4
Changes in Ownership
Wave Life Sciences, Inc. Filed Acc 0000899243-22-017133
Chief Financial Officer sold 5,021 shares at $1.72 ($8,636)
- Chief Financial Officer acquired 15,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Moran Kyle · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-05-04 | Grant or award : show line 1 in the form | +15,000 | 89,588 | D | ||
| 2022-05-05 | Sale : show line 2 in the form | −5,021 | $1.72 | $8,636 | 84,567 | D |
| Open-market sales · 5,021 sh · avg $1.72 · $8,636 | ||||||
Loading xslF345X03/doc4.xml…